Vikas Lifecare's Q1 FY25 Financial Results Show Decline in PBT, PAT, and Net Sales

Vikas Lifecare, a microcap company in the petrochemical industry, recently announced its financial results for the quarter ending June 2024. The company’s stock has been given a ‘Sell’ call by MarketsMOJO.

According to the financial report, Vikas Lifecare’s performance has remained flat in the last quarter, with a score of -4 compared to 20 in the previous three months. This indicates a decline in the company’s financial health.

The company’s Profit Before Tax (PBT) has fallen by -228.6% to Rs -2.21 crore, compared to the average PBT of the previous four quarters which was Rs -0.67 crore. This shows a negative trend in the near term for PBT.

Similarly, the Profit After Tax (PAT) has also seen a decline of -155.2% to Rs -2.82 crore, compared to the average PAT of the previous four quarters which was Rs 5.11 crore. This indicates a negative trend in the near term for PAT.

The Net Sales for the quarter were at Rs 92.09 crore, which is a decrease of -17.4% compared to the average Net Sales of the previous four quarters which was Rs 111.44 crore. This shows a very negative trend in the near term for sales.

Moreover, the Non Operating Income for the quarter was 7,466.67% of the PBT. This indicates that the company’s income from non-business activities is high, which may not be a sustainable business model.

In conclusion, Vikas Lifecare’s financial performance for the quarter ending June 2024 has been disappointing, with negative trends in PBT, PAT, and Net Sales. Investors are advised to take note of these factors before making any investment decisions.